Relevance: The autism debate is an issue which many of us are very concerned about on this forum and the links with big pharma and pizzagate have been demonstrated time and again over the years with the many posts. So, I have started to watch a series of videos of Stanley Plotkin's testimony in a vaccine case in Oakland, Michigan.. thanks to this link by @septimasexta here: https://voat.co/v/pizzagate/3308482/19488396
At circa 44:30m, in Stanley Plotkin, Godfather of vaccines, UNDER OATH Part 2 attorney Aaron Siri begins to list a number of board memberships in universities and private pharma companies that have not been listed on Plotkin's CV. I believe that looking through those affiliations may bring up some more pizzagate connections. I'll list those companies here and then provide one simple example.. this may or may not turn into a series.. it's time dependent for me but will be of use to other researchers..
Organisations listed by Siri: Sanofi, Glaxo, Merck, Pfizer consultancies; Dynavax Technologies;Vbi Vaccines Inc; Mimedx; Inovio; CureVac AG; SynVaccine Ltd.; Geovax Labs; GlycoVaxyn AG; Adjuvance Technologies; Bionet Asia; Abcombi Biosciences; Hookpia Pharma
Hookipa Board https://www.hookipapharma.com/leadership/board-of-directors/
Michael A. Kelly is an Independent Director to the Board of Directors of HOOKIPA Pharma. Michael is the Founder & President of Sentry Hill Partners, LLC, a global life sciences transformation and management consulting business and a former senior executive at Amgen, Inc. With more than two decades of global executive leadership in the life sciences industry, Michael A. Kelly was formerly Senior Vice President, Global Business Services and held various strategic finance and commercial operations positions at Amgen, including the role of acting CFO of Amgen, Inc. in 2010 and 2014 and positions at Biogen, Tanox and Monsanto Life Sciences.
...Michael A. Kelly is currently a member of the Board of Directors and serves on the Finance Committee for Direct Relief, a humanitarian aid organization focused on health outcomes and disaster relief.
Voat posts re Amgen:
Too many strange ties at The International Center for Missing & Exploited Children!
Amgen is one of the corrupt members of BioFlorida I had talked about....Amgen gave a crap ton of money to the Podesta group which seems pretty suspicious in and of itself. Anyway, they are a part of BioFlorida. BioFlorida had one member named RTI Surgical which was caught illegally selling Ukrainian organs, bone marrow, and tissue.
Aby Rosen of the CORE Club buys the Chrysler Building. He also owns the Gramercy Park Hotel, home to Maialino restaurant. What's that about a Podesta email and AMGEN?
Voat posts re Direct Relief:
International Planned Parenthood Federation, the world's biggest sexual health charity, is accused of offering YOUNG volunteers to adults at events in Africa...Here's what we know..
Several IFPMA pharmaceutical companies have been involved in efforts to develop Ebola vaccines. ..GSK also made donations of $64,000 each to humanitarian partners, AmeriCares and Direct Relief to enable these organisations to purchase and deliver critical supplies of personal protection equipment (PPE). Alongside this, GSK significantly increased medicine donations, with donated GSK products worth more than $1,122,500 to partners AmeriCares and Project HOPE....Bayer made medicines with a market value of $3.2 million available to Direct Relief free of charge to treat Ebola patients in Liberia and Sierra Leone. ..
https://voat.co/v/pizzagate/3228844/18708126 Direct Relief International is a big player with the Clinton Foundation. They can not only be linked with International Planned Parenthood Federation/Western Hemisphere Region (IPPF/WHR) https://www.clintonfoundation.org/clinton-global-initiative/commitments/zika-prevention-care
BUT ALSO
"The Sherman’s were heavily involved in philanthropy, which is where their paths crossed with the Clintons.
Barry Sherman’s pharma company Apotex was involved in the supply of generic pharmaceuticals under contracts with the Clinton Foundation most recently in Haiti and Rwanda....
https://voat.co/v/pizzagate/3228844/18713872 Clinton Foundation, Direct Relief and the Zika virus: https://www.clintonfoundation.org/clinton-global-initiative/commitments/zika-prevention-care..
https://voat.co/v/pizzagate/3228844/18718777 LOOK AT WHAT IS IN RACINE....."SC JOHNSON INSTITUTE OF INSECT SCIENCE FOR FAMILY HEALTH
One of Canada's richest billionaires and his wife found dead in their Mansion this week. Of course there's a connection to be found.
Barry Sherman was Chairman and CEO of Apotex, a Canadian pharm corp. I was curious of whether they did any 'humanitarian' work overseas, and, lo and behold…..In September 2014, in response to the spread of the chikungunya virus in Haiti, Apotex worked with the humanitarian organization Direct Relief to donate more than $2.2 million in medical aid to the country.
Shipping Containers used in Haiti for Maternal / Child Organization linked to Alefantis
Care2Communities partners: https://care2communities.org/our-work/partnerships/
One of them is Direct Relief. Am still new here, so bear with me, but I remember "suspicious" logos contain some kind of butterfly and spiral? If yes, this one does.
I've recently done a lot of work on shipping containers and this new information will really need some more time and research to add to the growing picture of trafficking. I hope the list of drug companies will be of interest to some of you.
view the rest of the comments →
septimasexta ago
Great research LDT. This can keep us busy for awhile.
Here's what I've dug up: "Organisations listed by Siri: Sanofi, Glaxo (Smith Kline: owned by WELLCOME TRUST), Merck, Pfizer consultancies; Dynavax Technologies...."
Plotkin was on the Science Board of the new hepatitis B vaccine with novel adjuvant 1018 ISS, Heplisav-B vaccine (Dynavax Technologies) and stepped down around the time it received ACIP and CDC recommendations (last 2 steps to get on the CDC Childhood Recommended Vaccines list)
"Press Release Mar 2, 2018 Stanley A. Plotkin, M.D. Steps Down from Board of Dynavax Technologies Dr. Plotkin Will Continue as Scientific Advisor BERKELEY, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (“Dynavax”) (NASDAQ:DVAX) announced today that Stanley A. Plotkin, M.D. has indicated his intention to step down from the Board of Directors (“Board”) effective from the 2018 Annual Shareholder Meeting on May 31, 2018.
“I am delighted that HEPLISAV-B has been launched and recommended by the ACIP,” Dr. Plotkin said. “When I originally joined the Dynavax Board many years ago it was because I knew that new adjuvants were needed to enhance the efficacy of vaccines. Now that licensure has been achieved, and in view of my desire to reduce my travel and wider commitments, I have made the decision to resign from the Board."
"About Dynavax Dynavax is a commercial-stage biopharmaceutical company focused on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Dynavax discovers and develops novel vaccines and immuno-oncology therapeutics. The Company’s first commercial product, HEPLISAV-B, a hepatitis B vaccine for adults, is approved in the United States." http://investors.dynavax.com/news-releases/news-release-details/stanley-plotkin-md-steps-down-board-dynavax-technologies
TIMELINE:
December 1987 Merck's RecombivaxHB patent
"Granted Sept. 6 to the inventors of the vaccine at the University of California, San Francisco and at the University of Washington. Patent covers the hepatitis B surface antigen produced from genetically engineered yeast and the Recombivax HB vaccine. In December 1987, Biogen received a patent covering the manufacture of "all hepatitis B surface and core antigens produced by genetic engineering." Biogen's technology is licensed to SmithKline ("The Pink Sheet" April 11, T&G-4). Merck maintains that any recombinant vaccine for hepatitis B produced through genetically engineered yeast falls under the claims of its patent." https://pink.pharmaintelligence.informa.com/PS014273/Mercks-Recombivax-HB-patent
June 7-8, 2000 "Scientific Review of Vaccine Safety Datalink Information, Simpsonwood Retreat Center, Norcross, GA" https://www.safeminds.org/wp-content/uploads/2014/03/simpsonwood-transcript-scientific-review-of-vaccine-safety-datalink-information.pdf SEE PAGE 4 OF THIS DOCUMENT. I believe the doctor referred to in this MARCH 1 2017 DOJ News release is the same: "EMORY DOCTOR GOES TO PRISON FOR DOWNLOADING THOUSANDS OF IMAGES OF CHILD PORNOGRAPHY" https://www.justice.gov/usao-ndga/pr/emory-doctor-goes-prison-downloading-thousands-images-child-pornography
"The din refused to fade and became shriller still when a freedom of information act petition by Congressman David Weldon exposed the minutes of a high profile meeting of 51 officials belonging to the CDC, vaccine manufacturers, and highly placed government officials who had met in Simpsonwood, Northcross Georgia, USA on 7th – 8th June 2000 to discuss two CDC studies that found undeniable association between mercury containing vaccines and autism. The relative risk found in both the studies was 7.62[42]; any figure above 1 being a sure indication.[43] CDC correspondence between the author Thomas Verstraeten and top notch scientists revealed he had manipulated the data at his level from a RR of 11.35 and unable to do so any further sent an SOS for help, "The association will not go away." Consequently the meeting was held where the guests decided to bury the association even as a member conceded his grandchild would not receive vaccines, another expressed concerns over targets to be met, while a third highlighted a similar role of the vaccine adjuvant aluminium which he felt had equally disastrous consequences. All of them agreed that these results should not reach the public.[44]" http://www.greenmedinfo.com/blog/anti-vaccination-pro-science-pro-health-anti-industry
August 27, 2010
Qui tam action filed against Merck for "...Merck's efforts for more than a decade to defraud the United States with respect to the efficacy of Merck's mumps vaccine." (FDA requires 95%) http://probeinternational.org/library/wp-content/uploads/2014/09/chatom-v-merck.pdf https://www.naturalnews.com/gallery/documents/Merck-False-Claims-Act.pdf
June 2015: " Whistleblower attorney accuses Merck of stonewalling by withholding information and files a motion to compel Merck to comply." https://ahrp.org/former-merck-scientists-sue-merck-alleging-mmr-vaccine-efficacy-fraud/
June 27, 2017 Merck claims "malware attack."
Up until this time, Merck's Recombivax HB was used exclusively in U.S.A since 1987 when it was introduced as the FIRST recombinant vaccine. The 1986 Vaccine Injury law allowed Big Pharma vaccine liability protection by the Federal Government. "Congress calls on Merck's Frazier to report on how much havoc malware attack wreaked on manufacturing by Eric Palmer | Sep 22, 2017 " https://www.fiercepharma.com/pharma/congress-calls-merck-ceo-frazier-to-report-extent-manufacturing-interruptions-from-petya https://www.courthousenews.com/wp-content/uploads/2017/09/Letter-to-Merck.pdf
July 2017 "Merck first announced a shortage in July 2017 citing demand and manufacturing process updates. It has pushed back its predicted availability several times and plans to allocate its supply to the CDC." https://www.aappublications.org/news/2018/11/13/hepbshortage111318 (Wellcome) GLAXO SMITH KLINE EngerixB made available for "birth dose" as a Merck substitute.
July 28, 2017
"Vaccines and Related Biological Products Advisory Committee Meeting: FDA Briefing Document: Heplisav-B (Hepatitis B Vaccine Recombinant and 1018 ISS Adjuvant: Applicant: Dynavax Technologies Corp." https://www.fda.gov/media/106641/download
February 21, 2018 "In February 2018, the ACIP recommended Heplisav-B be used in patients ≥18 years of age for vaccination against hepatitis B virus." https://www.clinicaladvisor.com/home/topics/hepatology-information-center/cdc-recommendations-on-the-use-of-heplisav-b-published/ https://www.cdc.gov/mmwr/volumes/67/wr/mm6715a5.htm
LOOK AT THE EFFICACY RATES: "The ACIP Hepatitis Vaccines Work Group conducted a systematic review of the evidence, including data from four randomized controlled trials assessing prevention of HBV infection and six randomized controlled trials assessing adverse events in adults. Seroprotective antibody to hepatitis B surface antigen (anti-HBs) levels were achieved in 90.0%–100.0% of subjects receiving HepB-CpG (Dynavax Technologies Corporation), compared with 70.5%–90.2% of subjects receiving Engerix-B (GlaxoSmithKline Biologicals)." Engerix-B is currently being used for the HepB birth dose to replace Merck's HepB vaccine. HeplisavB and its novel adjuvant has a FDA approved average 95% rate but can only be used for 18 and up. https://www.cdc.gov/mmwr/volumes/67/wr/mm6715a5.htm
November 13, 2018 "Merck HepB vaccine shortage to continue into 2019"
"Merck first announced a shortage in July 2017 citing demand and manufacturing process updates. It has pushed back its predicted availability several times and plans to allocate its supply to the CDC." https://www.aappublications.org/news/2018/11/13/hepbshortage111318
February 15, 2019 "Merck HepB vaccine shortage extended through 2019"
"GlaxoSmithKline (GSK) has an adequate supply of hepatitis B vaccine to make up for the shortage, according to the Centers for Disease Control and Prevention (CDC). The company produces single-component Engerix-B and combination vaccine Pediarix. Merck first announced a shortage in July 2017 citing demand and manufacturing process updates. It has pushed back its predicted availability several times and plans to allocate its supply to the CDC." https://www.aappublications.org/news/2019/02/15/hepbvaccineshortage021519
CURRENT 2019
California SB276 "(f) Effective immunizations not only protect immunized individuals from disease, but have the ability to provide indirect protection for which immunizations are not effective or safe. This indirect protection is called herd or community immunity. (g) Herd immunity successfully occurs if and when a sufficient portion of the community is immune. Herd immunity prevents sustained transmission of disease even when immunization coverage is below 100 percent." https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200SB276
NOTE: According to the Merck qui tam action case, 95% vaccine efficacy "is the efficacy threshold on which the FDA insists for its licensing and approval of the vaccine" https://www.naturalnews.com/gallery/documents/Merck-False-Claims-Act.pdf During HeplisavB efficacy trials, GSK's EngerixB was 70.5% - 90.2% Inadequate for "community immunity".
letsdothis3 ago
Thanks septimasexta. Great write up.
septimasexta ago
Actually this is research I had done prior to your post. It just happened to fit.
I find the timing of the "malware infection" at Merck quite interesting. It happened around the time the qui tam lawyers had to finish up collecting evidence in their case against Merck- which some say will go to trial in 2020. Was certain evidence "wiped"? Merck never directly says the malware attack was the cause of not manufacturing the HepB and Gardasil products- the only 2 affected. Both use aluminum adjuvants. Remember, in the Simpsonwood document one of the "consultants" also brings up the aluminum adjuvant in the HepB vaccine and a possible interaction with the mercury. The recombinant vaccines heavily rely on adjuvant to reach the 95% efficacy for FDA licensing. Merck only introduced its "new at the time" recombinant HepB vaccine in 1987- just after the 1986 Vaccine Injury law was passed which gave Big Pharma protection from liability lawsuits. For the first time, newborns were given a recombinant HepB vaccine containing aluminum adjuvant and mercury. Since HepB is sexually transmitted and is mainly a problem in third world countries, the main benefactors of the "birth dose" would be pedophiles- just my opinion. Remember, Stanley Plotkin was on boards of both Merck and Dynavax. While the CDC says that the remaining Merck HepB vax will be mixed in with the GSK Dynavax ONLY FOR THE BIRTH DOSE, conveniently, Merck has NO stock for the 18 and up adults. Enter the "just in time" approved HeplisavB vaccine with a NEVER BEFORE USED non-aluminum 1018 ISS adjuvant (shepherded through ACIP by Plotkin) to be used (GSK product also available) for 18 and up ADULTS. The new adjuvant affects the "Toll-like receptor-9" which theoretically can trigger an autoimmune response.
According to "Vaccines and Related Biological Products Advisory Committee Meeting: FDA Briefing Document: Heplisav-B (Hepatitis B Vaccine Recombinant and 1018 ISS Adjuvant: Applicant: Dynavax Technologies Corp." https://www.fda.gov/media/106641/download
on p. 10 "Non-clinical investigations of the potential for CpGs or Heplisav to induce autoimmunity have been suboptimal given the lack of an appropriate mouse or well-characterized NHP models of human autoimmunity."
The Simpsonwood meeting was actually looking at the then "new" Merck HepB vaccine- not just mercury. The stats which produced an alarming RR 7.6 for AUTISM were based on a comparison group- one had the full vaccine schedule, including the HepB birth dose, The other group had same vaccine schedule EXCEPT the HepB birth dose.
septimasexta ago
Notice the recent "board slide?"